Advanced search
Publication Cover
Journal of Chemotherapy Volume 14, 2002 - Issue 6
Submit an article Journal homepage
10
Views
2
CrossRef citations to date
0
Altmetric
Articles

Comparative In Vitro Activity of Quinupristin/Dalfopristin and Seven Other Antimicrobials Against Methicillin-Susceptible and Methicillin-Resistant Nosocomial Staphylococcus aureus Bloodstream Isolates

P. Nikolaidis
,
S. Metallidis
,
E. Katikaridou
,
M. Chatzidimitriou
,
P. Kollaras
,
A. Tsona
,
E. Koumentaki
&
A. Tourkantonis
 show all
Pages 544-546 | Published online: 18 Jul 2013

References

  • Bryson HM, Spencer CM. Quinupristin-dalfopristin. Drugs 1996; 52: 406–415.
  • Bouanchaud DH. In-vitro and in-vivo synergistic activity and fractional inhibitory concentration (FIC) of the compo-nents of the semisynthetic streptogramin, PR 59500. J Antimicrob Chemother 1992; 30, Supplement A: 95-99.
  • Cormican MG, Jones RN. Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococci. Drugs 1996; 51 Supplement 1: 6-12.
  • Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infection in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991; 91 supplement 3B: 86S-89S.
  • Jarvis WR, Martone WJ. Predominant pathogens in hos-pital infections. J Antimicrob Chemother 1992; 29 supple-ment A: 19-24.
  • Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of infection in Intensive Care (EPIC) study. JAMA 1995; 274 (8): 639–44.
  • Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Contr Hosp Epidem 1992; 13: 700–5.
  • Marinus A, Schouten MA, Hoogkamp-Korstanje JAA. Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates. J Antimicrob Chemother 1997; 40: 213–9.
  • Jones RN, Ballow CH, Biedenbach DJ, Deinhart JA, Schentag JJ. Antimicrobial activity of quinupristin-dalfopristin (PR 59500, Synercid) tested against over 28,000 recent clini-cal isolates from 200 medical centers in the United States and Canada. Diagn Microbiol Infect Dis 1998; 31 (3): 437–51.
  • Low DE, Nadler HL. A review of in-vitro activity of quinupristin-dalfopristin against methicillin-susceptible and - resistant Staphylococcus aureus. J Antimicrob Chemother 1997; 39 Supplement A: 53-58.
  • Luh KT, Hsueh PR, Teng IA et al. Quinopristin-dalfo-pristin resistance among Gram-positive bacteria in Taiwan. Antimicrob Agents Chemother 2000; 44 (12): 3374–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.